Regional differences in expression of β-tubulin isoforms in schizophrenia

Schizophrenia Research

Volumn 135, Issue 1-3, 2012, Pages 181-186

  Moehle, Mark S ^a   Luduena, Richard F ^b   Haroutunian, Vahram ^c   Meador Woodruff, James H ^a   McCullumsmith, Robert E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Texas Health Science Center at San Antonio   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Anterior cingulate cortex; Dorsal lateral prefrontal cortex; Postmortem; Western blot

Indexed keywords

BETA I TUBULIN; BETA II TUBULIN; BETA III TUBULIN; BETA IV TUBULIN; BETA TUBULIN; ISOPROTEIN; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG;

AGE; AGED; ANTERIOR CINGULATE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG USE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SUPERIOR TEMPORAL GYRUS; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; PROTEIN ISOFORMS; SCHIZOPHRENIA; TEMPORAL LOBE; TUBULIN;

EID: 84857233457     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.12.010     Document Type: Article

References (36)

1. Bachus S.E., Hyde T.M., Herman M.M., Egan M.F., Kleinman J.E. Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics. J. Psychiatr. Res. 1997, 31(2):233-256.
2. Banerjee A., Roach M.C., Trcka P., Luduena R.F. Preparation of a monoclonal antibody specific for the class IV isotype of beta-tubulin. Purification and assembly of alpha beta II, alpha beta III, and alpha beta IV tubulin dimers from bovine brain. J. Biol. Chem. 1992, 267(8):5625-5630.
3. Banerjee A., Roach M.C., Trcka P., Ludueña R.F. Increased microtubule assembly in bovine brain tubulin lacking the type III isotype of beta-tubulin. J. Biol. Chem. 1990, 265(3):1794-1799.
4. Banerjee A., Roach M.C., Wall K.A., Lopata M.A., Cleveland D.W., Ludueña R.F. A monoclonal antibody against the type II isotype of beta-tubulin. Preparation of isotypically altered tubulin. J. Biol. Chem. 1988, 263(6):3029-3034.
5. Barros C.S., Calabrese B., Chamero P., Roberts A.J., Korzus E., Lloyd K., Stowers L., Mayford M., Halpain S., Müller U. Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(11):4507-4512.
6. Bauer D., Gupta D., Harotunian V., Meador-Woodruff J.H., McCullumsmith R.E. Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia. Schizophr. Res. 2008, 104(1-3):108-120.
7. Bauer D.E., Haroutunian V., McCullumsmith R.E., Meador-Woodruff J.H. Expression of four housekeeping proteins in elderly patients with schizophrenia. J. Neural Transm. 2009, 116(4):487-491.
8. Beasley C.L., Pennington K., Behan A., Wait R., Dunn M.J., Cotter D. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. Proteomics 2006, 6(11):3414-3425.
9. Behan A.T., Byrne C., Dunn M.J., Cagney G., Cotter D.R. Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. Mol. Psychiatry 2009, 14(6):601-613.
10. Black J.E., Kodish I.M., Grossman A.W., Klintsova A.Y., Orlovskaya D., Vostrikov V., Uranova N., Greenough W.T. Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am. J. Psychiatry 2004, 161(4):742-744.
11. Bond D., Primrose D.A., Foley E. Quantitative evaluation of signaling events in Drosophila S2 cells. Biol. Proced. Online 2008, 10:20-28.
12. Budel S., Padukkavidana T., Liu B.P., Feng Z., Hu F., Johnson S., Lauren J., Park J.H., McGee A.W., Liao J., Stillman A., Kim J.E., Yang B.Z., Sodi S., Gelernter J., Zhao H., Hisama F., Arnsten A.F., Strittmatter S.M. Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J. Neurosci. 2008, 28(49):13161-13172.
13. Chan M.K., Tsang T.M., Harris L.W., Guest P.C., Holmes E., Bahn S. Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients. Mol. Psychiatry 2011, 16:1189-1202.
14. Chen Y.J., Johnson M.A., Lieberman M.D., Goodchild R.E., Schobel S., Lewandowski N., Rosoklija G., Liu R.C., Gingrich J.A., Small S., Moore H., Dwork A.J., Talmage D.A., Role L.W. Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J. Neurosci. 2008, 28(27):6872-6883.
15. Clark D., Dedova I., Cordwell S., Matsumoto I. A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Mol. Psychiatry 2006, 11(5). 459-470, 423.
16. Clinton S.M., Haroutunian V., Meador-Woodruff J.H. Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia. J. Neurochem. 2006, 98(4):1114-1125.
17. English J.A., Dicker P., Föcking M., Dunn M.J., Cotter D.R. 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease. Proteomics 2009, 9(12):3368-3382.
18. Ghiani C.A., Starcevic M., Rodriguez-Fernandez I.A., Nazarian R., Cheli V.T., Chan L.N., Malvar J.S., de Vellis J., Sabatti C., Dell'Angelica E.C. The dysbindin-containing complex (BLOC-1) in brain: developmental regulation, interaction with SNARE proteins and role in neurite outgrowth. Mol. Psychiatry 2010, 15(2). 115, 204-115.
19. Ghose S., Chin R., Gallegos A., Roberts R., Coyle J., Tamminga C. Localization of NAAG-related gene expression deficits to the anterior hippocampus in schizophrenia. Schizophr. Res. 2009, 111(1-3):131-137.
20. Guo J., Walss-Bass C., Ludueña R.F. The beta isotypes of tubulin in neuronal differentiation. Cytoskeleton (Hoboken) 2010, 67(7):431-441.
21. Hayashi-Takagi A., Takaki M., Graziane N., Seshadri S., Murdoch H., Dunlop A.J., Makino Y., Seshadri A.J., Ishizuka K., Srivastava D.P., Xie Z., Baraban J.M., Houslay M.D., Tomoda T., Brandon N.J., Kamiya A., Yan Z., Penzes P., Sawa A. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 2010, 13(3):327-332.
22. Katsel P., Davis K.L., Gorman J.M., Haroutunian V. Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophr. Res. 2005, 77(2-3):241-252.
23. Katsel P., Davis K.L., Haroutunian V. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr. Res. 2005, 79(2-3):157-173.
24. Kristiansen L.V., Bakir B., Haroutunian V., Meador-Woodruff J.H. Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia. Schizophr. Res. 2010, 119(1-3):198-209.
25. Kristiansen L.V., Beneyto M., Haroutunian V., Meador-Woodruff J.H. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol. Psychiatry 2006, 11(8). 737-747, 705.
26. Lenadro-Garcia L.J., Leskelä A., Landa I., Montero-Conde C., López-Jiménez E., Letón R., Cascón Alberto, Robledo M., Rodríguez-Antona C. Tumoral and tissue-specific expression of the major human β-tubulin isotypes. Cytoskeleton 2010, 67:214-223.
27. Lezama R., Castillo A., Luduena R.F., Meza I. Over-expression of betaI tubulin in MDCK cells and incorporation of exogenous betaI tubulin into microtubules interferes with adhesion and spreading. Cell Motil. Cytoskeleton 2001, 50(3):147-160.
28. Li B., Woo R.S., Mei L., Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 2007, 54(4):583-597.
29. Martins-de-Souza D., Schmitt A., Röder R., Lebar M., Schneider-Axmann T., Falkai P., Turck C.W. Sex-specific proteome differences in the anterior cingulate cortex of schizophrenia. J. Psychiatr. Res. 2010, 44(14):989-991.
30. Oni-Orisan A., Kristiansen L.V., Haroutunian V., Meador-Woodruff J.H., McCullumsmith R.E. Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia. Biol. Psychiatry 2008, 63(8):766-775.
31. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T., Griffin J.L., Wayland M., Freeman T., Dudbridge F., Lilley K.S., Karp N.A., Hester S., Tkachev D., Mimmack M.L., Yolken R.H., Webster M.J., Torrey E.F., Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 2004, 9(7). 684-697, 643.
32. Selemon L.D., Lidow M.S., Goldman-Rakic P.S. Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biol. Psychiatry 1999, 46(2):161-172.
33. Selemon L.D., Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 1999, 45:17-25.
34. Sivagnanasundaram S., Crossett B., Dedova I., Cordwell S., Matsumoto I. Abnormal pathways in the genu of the corpus callosum in schizophrenia pathogenesis: a proteome study. Proteomics Clin. Appl. 2007, 1(10):1291-1305.
35. Stan A.D., Ghose S., Gao X.M., Roberts R.C., Lewis-Amezcua K., Hatanpaa K.J., Tamminga C.A. Human postmortem tissue: what quality markers matter?. Brain Res. 2006, 1123(1):1-11.
36. Sweet R.A., Henteleff R.A., Zhang W., Sampson A.R., Lewis D.A. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology 2009, 34(2):374-389.